Porter J, Anderson J, Carter L, Donjacour E, Paros M
Biological Sciences, The Evergreen State College, 1700 Evergreen Pkwy NW Olympia, WA 98505.
Biological Sciences, The Evergreen State College, 1700 Evergreen Pkwy NW Olympia, WA 98505.
J Dairy Sci. 2016 Mar;99(3):2053-2062. doi: 10.3168/jds.2015-9748. Epub 2016 Jan 13.
The objective of this study was to investigate the potential use of bacteriophage in preventing Escherichia coli mastitis on dairies. A cocktail consisting of 4 distinct bacteriophages was generated by screening against 36 E. coli isolates from dairy cows in Washington State with clinical mastitis. The bacteriophage significantly inhibited growth of 58% of the Washington State isolates and 54% of E. coli mastitis isolates from New York State, suggesting that the cocktail of phages had a relatively broad spectrum of action against relevant strains from 2 distinct geographies. The ability to suppress bacterial growth of these isolates in a liquid growth medium was not affected by the ratio of bacteriophage particles to bacterial cells (multiplicity of infection, MOI). For those E. coli that were completely inhibited by the phage cocktail, an MOI as low as 10 had the same effect as 10 µg/mL of ceftiofur on the growth rate of E. coli over a 12-h period using optical density measurements. A 3.3- to 5.6-log reduction of growth was achieved when E. coli was co-incubated with our phage cocktail in raw milk over a 12-h period at physiologic temperature. A modified gentamicin protection assay using bovine mammary epithelial cells provided a model to test whether bacteriophage could prevent cell attachment and invasion by chronic coliform mastitis strains. Pretreatment of cell cultures with the phage cocktail significantly reduced adhesion and intracellular survival of E. coli compared with controls. When combined with a bismuth-based teat sealant, the phage cocktail was able to inhibit bacterial growth when challenged with 1.6 × 10(3) cfu/mL of a clinical mastitis E. coli strain. In vitro results show bactericidal activity by our phage in raw milk and mammary tissue culture systems. Before a bacteriophage-based dry-cow treatment becomes a potential option for dairies, in vivo studies must be able to demonstrate that a specific dose of bacteriophage can protect cows from experimentally induced E. coli mastitis without inducing an inflammatory reaction.
本研究的目的是调查噬菌体在预防奶牛场大肠杆菌性乳腺炎方面的潜在用途。通过对华盛顿州患有临床乳腺炎的奶牛的36株大肠杆菌分离株进行筛选,产生了一种由4种不同噬菌体组成的混合物。该噬菌体显著抑制了58%的华盛顿州分离株和54%的来自纽约州的大肠杆菌性乳腺炎分离株的生长,这表明噬菌体混合物对来自两个不同地区的相关菌株具有相对广泛的作用谱。在液体生长培养基中抑制这些分离株细菌生长的能力不受噬菌体颗粒与细菌细胞比例(感染复数,MOI)的影响。对于那些被噬菌体混合物完全抑制的大肠杆菌,使用光密度测量,在12小时内,低至10的MOI对大肠杆菌生长速率的影响与10μg/mL头孢噻呋相同。当大肠杆菌与我们的噬菌体混合物在生理温度下于原料奶中共孵育12小时时,实现了3.3至5.6个对数级的生长减少。使用牛乳腺上皮细胞的改良庆大霉素保护试验提供了一个模型,以测试噬菌体是否可以预防慢性大肠菌性乳腺炎菌株的细胞附着和侵袭。与对照相比,用噬菌体混合物预处理细胞培养物可显著降低大肠杆菌的粘附和细胞内存活。当与铋基乳头密封剂联合使用时,噬菌体混合物在受到1.6×10(3) cfu/mL临床乳腺炎大肠杆菌菌株攻击时能够抑制细菌生长。体外结果显示我们的噬菌体在原料奶和乳腺组织培养系统中具有杀菌活性。在基于噬菌体的干奶期治疗成为奶牛场的潜在选择之前,体内研究必须能够证明特定剂量的噬菌体可以保护奶牛免受实验性诱导的大肠杆菌性乳腺炎的侵害,而不会引发炎症反应。
Folia Microbiol (Praha). 2019-6-30
Front Cell Infect Microbiol. 2021
Front Vet Sci. 2025-5-23
Naunyn Schmiedebergs Arch Pharmacol. 2025-6-6
Vet Res Commun. 2025-3-24
Anim Biosci. 2025-7
J Anim Sci Technol. 2024-1
mBio. 2024-1-16
Antibiotics (Basel). 2023-8-10